QRR

Filler, Bone Void, Calcium Compound Containing Single Approved Aminoglycoside

Product code
QRR
Device name
Filler, Bone Void, Calcium Compound Containing Single Approved Aminoglycoside
Device class
Class 2
21 CFR
21 CFR 888.3046
Medical specialty
Orthopedic
Marketing pathway
510(K)
Flag
Implant
510(k) clearances (last 3 years)
2

FDA classification definition

A resorbable calcium salt bone void filler containing a single approved aminoglycoside antibacterial is a resorbable implant intended to fill bony defects of the extremities where there is an increased risk of infection. It is intended to resorb over time and be replaced by new bone. The product is intended for reduction of recurrence of chronic osteomyelitis of long bones. It is not intended to treat infection.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2024-03-13.

NumberDecision dateApplicantDevice nameSummary
K2340082024-03-13Bonesupport ABCERAMENT GPDF

1 summaries are archived here for direct download.

Official FDA classification page: QRR
Classification and pathway per current FDA publications. Data from openFDA (CC0).